Many plant-derived alkaloids that act as AChE inhibitors (AChE-I) are available for the symptomatic treatment of patients with mild to moderate AD and can be considered as models for the development of anti-Alzheimer drugs. The gene discussed is ACHE; the disease is Alzheimer disease.